Stockreport

Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications

Axonics, Inc.  (AXNX) 
Last axonics, inc. earnings: 3/4 04:01 pm Check Earnings Report
PDF IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel i [Read more]